Self-monitoring of blood glucose for patients with diabetes on insulin therapy is considered an essential part of management. However, the clinical benefit of regular testing for most patients with type 2 diabetes not using insulin, has been questioned, with concerns that frequent testing could even lead to decreased quality of life.
The ODPRN has conducted multiple studies on blood glucose test strips (BGTS) primarily focusing on the impact of BGTS quantity limits on utilization, costs and patient outcomes.
Provincial governments across Canada have implemented blood glucose test strip (BGTS) quantity limits to encourage proper testing practices for optimal patient outcomes. The ODPRN has developed a provincial list of implementation details for each province as of June 2017.
Access the list here